HUNT RONALD — SEC Form 4 filings
SEC reporting owner CIK 1247851. 7 Form 4 filings on record with FilingPulse; latest filed 2026-02-20.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-03-11 to 2026-02-20. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 26.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Harpoon Therapeutics, Inc. (HARP) | Director, 10% owner | 1 | — | — | 12 |
| Iterum Therapeutics plc (ITRM) | Director | 2 | — | — | 10 |
| Rallybio Corp (RLYB) | Director | 4 | — | — | 4 |
Form 4 filings — HUNT RONALD
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-02-20 | 4 | Rallybio Corp (RLYB) | Grant/award (A): 14,305 (derivative) @ $3.60 | EDGAR |
| 2025-05-15 | 4 | Rallybio Corp (RLYB) | Grant/award (A): 28,500 (derivative) @ $0 | EDGAR |
| 2025-01-23 | 4 | Iterum Therapeutics plc (ITRM) | Other (J) @ $2,208,000 · Other (J) @ $792,000 | EDGAR |
| 2025-01-06 | 4 | Rallybio Corp (RLYB) | Grant/award (A): 73,571 (derivative) @ $0.70 | EDGAR |
| 2024-08-12 | 4 | Iterum Therapeutics plc (ITRM) | Option exercise (M): 182,453 · Option exercise (M): 65,481 · Option exercise (M): 364,906 (derivative) @ $0 · Option exercise (M): 182,453 (derivative) · Option exercise (M): 182,453 (derivative) · Option exercise (M): 130,962 (derivative) @ $0 · +2 more | EDGAR |
| 2024-05-17 | 4 | Rallybio Corp (RLYB) | Grant/award (A): 16,500 (derivative) @ $0 | EDGAR |
| 2024-03-11 | 4 | Harpoon Therapeutics, Inc. (HARP) | Grant/award (A): 424 @ $0 · Disposition to issuer (D): 13,224 · Disposition to issuer (D): 1,463,386 · Disposition to issuer (D): 395,783 · Disposition to issuer (D): 10,000 · Disposition to issuer (D): 299,430 (derivative) · +6 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1247851 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →